Caroline Fenton

1.5k total citations
47 papers, 1.1k citations indexed

About

Caroline Fenton is a scholar working on Infectious Diseases, Dermatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Caroline Fenton has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Dermatology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Caroline Fenton's work include SARS-CoV-2 and COVID-19 Research (3 papers), Blood Pressure and Hypertension Studies (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Caroline Fenton is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Blood Pressure and Hypertension Studies (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Caroline Fenton collaborates with scholars based in New Zealand, United Kingdom and Australia. Caroline Fenton's co-authors include Katherine A. Lyseng‐Williamson, Gillian M. Keating, Lesley J. Scott, Greg L. Plosker, Caroline M. Perry, Rachael Thomson, Rachel Tolhurst, S. Bertel Squire, A. Medina Lara and Sally Theobald and has published in prestigious journals such as The Lancet Infectious Diseases, Drugs and CNS Drugs.

In The Last Decade

Caroline Fenton

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Fenton New Zealand 16 209 169 140 132 131 47 1.1k
Thomas J. Hwang United States 25 192 0.9× 201 1.2× 225 1.6× 201 1.5× 170 1.3× 94 2.1k
Yong Wu China 18 102 0.5× 315 1.9× 200 1.4× 209 1.6× 75 0.6× 78 1.2k
Denese C. Marks Australia 29 150 0.7× 340 2.0× 223 1.6× 194 1.5× 72 0.5× 135 2.5k
J.M. Carrascosa Spain 30 188 0.9× 227 1.3× 145 1.0× 154 1.2× 317 2.4× 211 3.0k
Sumihiro Suzuki United States 17 190 0.9× 222 1.3× 118 0.8× 72 0.5× 250 1.9× 74 1.1k
Huan He China 24 168 0.8× 443 2.6× 193 1.4× 191 1.4× 222 1.7× 80 1.6k
Joseph E. Kiss United States 32 255 1.2× 312 1.8× 155 1.1× 159 1.2× 346 2.6× 130 3.3k
Mary E. Walker United States 20 314 1.5× 250 1.5× 115 0.8× 35 0.3× 180 1.4× 63 1.5k
Sarah Garner United Kingdom 26 121 0.6× 220 1.3× 143 1.0× 59 0.4× 193 1.5× 60 2.4k
Jing Sun China 19 120 0.6× 284 1.7× 92 0.7× 146 1.1× 197 1.5× 107 1.5k

Countries citing papers authored by Caroline Fenton

Since Specialization
Citations

This map shows the geographic impact of Caroline Fenton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Fenton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Fenton more than expected).

Fields of papers citing papers by Caroline Fenton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Fenton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Fenton. The network helps show where Caroline Fenton may publish in the future.

Co-authorship network of co-authors of Caroline Fenton

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Fenton. A scholar is included among the top collaborators of Caroline Fenton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Fenton. Caroline Fenton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fenton, Caroline & Connie Kang. (2023). Clozapine is the approved option in treatment-resistant schizophrenia and requires careful management. Drugs & Therapy Perspectives. 39(3). 107–113. 12 indexed citations
2.
Fenton, Caroline & Connie Kang. (2023). Consider new therapies for the treatment and prevention of Clostridioides difficile infection. Drugs & Therapy Perspectives. 39(7). 237–242. 1 indexed citations
3.
Fenton, Caroline & Arnold Lee. (2022). mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisation. Drugs & Therapy Perspectives. 38(12). 532–540. 4 indexed citations
4.
Fenton, Caroline & Connie Kang. (2021). Managing glucose-related adverse events of antipsychotics is worth the effort. Drugs & Therapy Perspectives. 37(9). 415–421. 1 indexed citations
5.
Fenton, Caroline & Connie Kang. (2021). Eczematous drug eruptions mostly manageable with emollients and corticosteroids. Drugs & Therapy Perspectives. 38(1). 13–18.
6.
Fenton, Caroline & Connie Kang. (2020). Other options usually better than benzodiazepines in alleviating dyspnoea, sleeping problems and anxiety in COPD patients. Drugs & Therapy Perspectives. 37(1). 19–24. 1 indexed citations
7.
Fenton, Caroline & Katherine A. Lyseng‐Williamson. (2020). Methadone is an option to treat cancer pain in carefully selected patients. Drugs & Therapy Perspectives. 36(11). 502–508. 1 indexed citations
8.
Fenton, Caroline & Connie Kang. (2020). Managing PFAPA (periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis) in children. Drugs & Therapy Perspectives. 37(2). 65–69. 1 indexed citations
9.
Fenton, Caroline, et al.. (2009). Drospirenone/Ethinylestradiol 3mg/20microgr (24/4 Day Regimen) A Review of Use in Contraception, Premenstrual Dysphoric Disorder and Moderate Acne Vulgaris. 22. 83–84. 7 indexed citations
10.
Fenton, Caroline & Caroline M. Perry. (2006). Spotlight on Gemtuzumab Ozogamicin in Acute Myeloid Leukaemia1. BioDrugs. 20(2). 137–139. 4 indexed citations
11.
Fenton, Caroline, Keri Wellington, & Stephanie E. Easthope. (2006). 0.4% Nitroglycerin Ointment. Drugs. 66(3). 343–349. 27 indexed citations
12.
Fenton, Caroline & Caroline M. Perry. (2006). Verteporfin. Drugs & Aging. 23(5). 421–445. 18 indexed citations
13.
Fenton, Caroline, Gillian M. Keating, & Katherine A. Lyseng‐Williamson. (2006). Moxonidine. Drugs. 66(4). 477–496. 61 indexed citations
14.
Fenton, Caroline & Caroline M. Perry. (2005). Gemtuzumab Ozogamicin. Drugs. 65(16). 2405–2427. 31 indexed citations
15.
Fenton, Caroline & Lesley J. Scott. (2005). Candesartan Cilexetil. Drugs. 65(4). 537–558. 14 indexed citations
16.
Fenton, Caroline & Lesley J. Scott. (2005). Risperidone. CNS Drugs. 19(5). 429–444. 43 indexed citations
17.
Fenton, Caroline, Gillian M. Keating, & Antona J. Wagstaff. (2004). Valdecoxib. Drugs. 64(11). 1231–1261. 70 indexed citations
18.
Fenton, Caroline, Lesley J. Scott, & Greg L. Plosker. (2004). Palivizumab. Pediatric Drugs. 6(3). 177–197. 53 indexed citations
19.
Fenton, Caroline, Gillian M. Keating, & Monique P Curran. (2004). Daptomycin. Drugs. 64(4). 445–455. 53 indexed citations
20.
Fenton, Caroline, Gillian M. Keating, & Greg L. Plosker. (2003). Novolizer??. Drugs. 63(22). 2437–2445. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026